The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: A meta-analysis

Journal of Evidence-Based Medicine

Volumn 7, Issue 4, 2014, Pages 263-269

  Zhang, Lei ^a   Chen, Ling Min ^a   Wang, Man Ni ^a   Chen, Xiang Jun ^a   Li, Nian ^a   De Huang, Ying ^a   Chen, Min ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer risk; Endothelial nitric oxide synthase; Gene polymorphism; Meta analysis

Indexed keywords

ASIAN; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DATA BASE; DISEASE ASSOCIATION; EMBASE; ENOS GENE; ETHNICITY; GENE; GENETIC RISK; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; PUBLISHING; REVIEW; RISK FACTOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NEOPLASMS; RISK;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 84913614279     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/jebm.12126     Document Type: Review

References (24)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 2013; 63(1): 11-30.
2. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2(8670): 997-1000.
3. Prabhu V, Guruvayoorappan C. Nitric oxide: pros and cons in tumor progression. Immunopharmacology and Immunotoxicology 2010; 32(3): 387-92.
4. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19(5): 711-21.
5. Li YY. Endothelial nitric oxide synthase G894T gene polymorphism and essential hypertension in the Chinese population: a meta-analysis involving 11, 248 subjects. Internal Medicine (Tokyo, Japan) 2011; 50(19): 2099-2106.
6. Luo JQ, Wen JG, Zhou HH, Chen XP, Zhang W. Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21, 068 subjects. PloS One 2014; 9(1): e87196
7. Dai B, Liu T, Zhang B, Zhang X, Wang Z. The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis. Gene 2013; 519(1): 187-93.
8. Hao Y, Montiel R, Huang Y. Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment 2010; 124(3): 809-13.
9. Zintzaras E, Grammatikou M, Kitsios GD, Doxani C, Zdoukopoulos N, Papandreou C, et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association study and meta-analysis. Journal of Human Genetics 2010; 55(11): 743-48.
10. Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, et al. Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009; 30(5): 777-84.
11. Yang J, Ambrosone CB, Hong CC, Ahn J, Rodriguez C, Thun MJ, et al. Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 2007; 28(6): 1247-53.
12. Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiology, Biomarkers & Prevention 2007; 16(9): 1784-94.
13. Lee KM, Choi JY, Lee JE, Noh DY, Ahn SH, Han W, et al. Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Research and Treatment 2007; 106(3): 433-38.
14. Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, et al. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecologic Oncology 2004; 93(3): 686-90.
15. Marangoni K, Neves AF, Cardoso AM, Santos WK, Faria PC, Goulart LR. The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detection and Prevention 2006; 30(1): 7-13.
16. Ziaei SA, Samzadeh M, Jamaldini SH, Afshari M, Haghdoost AA, Hasanzad M. Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer. The International Journal of Biological Markers 2013; 28(1): 43-48.
17. Brankovic A, Brajuskovic G, Nikolic Z, Vukotic V, Cerovic S, Savic-Pavicevic D, et al. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population. International Journal of Experimental Pathology 2013; 94(6): 355-61.
18. Ghilardi G, Biondi ML, Cecchini F, DeMonti M, Guagnellini E, Scorza R. Vascular invasion in human breast cancer is correlated to T->786C polymorphism of NOS3 gene. Nitric Oxide 2003; 9(2): 118-22.
19. Hefler LA, Grimm C, Lantzsch T, Lampe D, Koelbl H, Lebrecht A, et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Research and Treatment 2006; 98(2): 151-55.
20. Arikan S, Cacina C, Guler E, Culcu S, Tuna G, Yaylim-Eraltan I. The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Molecular Biology Reports 2012; 39(3): 3245-49.
21. Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009; 30(4): 621-25.
22. Zhang Y, Jia Q, Xue P, Liu Y, Xiong T, Yang J, et al. The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk. Tumour Biology 2014; 35(4): 3535-40.
23. Medeiros RM, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, et al. Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clinical Cancer Research 2002; 8(11): 3433-37.
24. Li B, Tan B, Chen C, Zhao L, Qin L. Association between the ABO blood group and risk of common cancers. Journal of Evidence-Based Medicine 2014; 7: 79-83.